Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00677846|
Recruitment Status : Unknown
Verified May 2008 by University Hospital Freiburg.
Recruitment status was: Recruiting
First Posted : May 15, 2008
Last Update Posted : May 15, 2008
During the repair process of deep venous thrombosis, capillary formation is seen from day 18 to day 25. Contrast agent investigation is well known to detect small vessels in arterial disease. We intend to use this method to detect early vascularisation in the thrombus, in order to get more information about the evolution of the thrombosis in vivo.
Aims of the study:
Investigation of a newly diagnosed occluding venous thrombus with duplexsonography, using contrast agent and compare the degree of vascularization in the same patient after 3 weeks and 3 months. The relative signal intensity difference (baseline to peak) of the time intensity curve (TIC) is measured in defined region of interests (ROI). Comparison of the visibility of revascularisation between color duplexsonography, power mode and contrast agent will be done.
Patients with venous thrombosis of the proximal limb veins (femoral or popliteal vein) will be investigated with ultrasound agent in supine position. 5 ml of the contrast agent sulfur hexafluoride is given intravenously into a vein of the dorsal foot. The measurements are done in a defined area, where the thrombus is fully occluding in color Doppler investigation. The regions of interest will be the vessel walls and the centre of the thrombus in cross section view. The signal intensities are measured at baseline and peak (in decibel) in the centre and in the peripheral part of the vein. 20 patients with acute deep venous thrombosis will be included in this pilot study and investigated at baseline, after 3 weeks and 3 months.
Previously (before contrast agent application), the veins are investigated with color - and power Doppler to test visibility in comparison to the contrast agent investigation.
|Condition or disease|
|Deep Venous Thrombosis|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||31 participants|
|Official Title:||Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging, a Follow up Study|
|Study Start Date :||April 2007|
|Estimated Primary Completion Date :||July 2008|
|Estimated Study Completion Date :||August 2008|
Patients with symptoms of deep venous thrombosis less than for 2 weeks, with thrombus occluding without any reperfusion in color mode in the common femoral vein (CFV), the femoral vein (FV) or the popliteal vein (PV)
- Vascularisation in thrombosis in patients with initially occluded veins, assessed with ultrasound contrast agent (relative difference between baseline and peak of the time intensity curve) [ Time Frame: 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00677846
|University of Freiburg||Recruiting|
|Freiburg, Baden Würtemberg, Germany, 79110|
|Contact: Christina R. Jeanneret-Gris, MD 41-61-436-2060 ext 2780 firstname.lastname@example.org|
|Principal Investigator:||Christina R. Jeanneret-Gris, MD||University of Freiburg|